Study Title: Prospective assessment of patients with neuroendocrine tumors and current or prior history of carcinoid syndrome or diarrhea undergoing peptide receptor radionuclide therapy with or without telotristat ethyl (NET-PACS Trial) Big Ten Cancer Research Consortium BTCRC-GI19-400
 

• Status: Terminated

• Participating Sites:
  • Holden Comprehensive Cancer Center, University of Iowa
• Learn more:
  • clinicaltrials.gov: NCT04713202